Melatonin reduces apoptotic cells,SOD2 and HSPB1 and improves the in vitro production and quality of bovine blastocysts

Effects of adding different concentrations of melatonin (10^?7, 10^?9 and 10^?11 M) to maturation (Experiment 1; Control, IVM  + 10^?7, IVM  + 10^?9, IVM  + 10^?11) and culture media (Experiment 2; Control, IVC  + 10^?7, IVC  + 10^?9, IVC  + 10^?11) were evaluated on in vitro bovine embryonic development. The optimal concentration of melatonin (10^?9 M) from Experiments 1–2 was tested in both maturation and/or culture media of Experiment 3 (Control, IVM  + 10^?9, IVC  + 10^?9, IVM /IVC  + 10^?9). In Experiment 1, maturated oocytes from Control and IVM  + 10^?9 treatments showed increased glutathione content, mitochondrial membrane potential and percentage of Grade I blastocysts (40.6% and 43%, respectively). In Experiment 2, an increase in the percentage of Grade I blastocysts was detected in IVC  + 10^?7 (43.5%; 56.7%) and IVC  + 10^?9 (47.4%; 57.4%). Moreover, a lower number and percentage of apoptotic cells in blastocysts were observed in the IVC  + 10^?9 group compared to Control (3.8 ± 0.6; 3.6% versus 6.1 ± 0.6; 5.3%). In Experiment 3, the IVC  + 10^?9 treatment increased percentage of Grade I blastocysts with a lower number of apoptotic cells compared to IVM /IVC  + 10^?9 group (52.6%; 3.0 ± 0.5 versus 46.0%; 5.4 ± 1.0). The IVC  + 10^?9 treatment also had a higher mRNA expression of antioxidant gene (SOD 2) compared to the Control, as well as the heat shock protein (HSPB 1) compared to the IVM  + 10^?9. Reactive oxygen species production was greater in the IVM /IVC  + 10^?9 treatment group. In conclusion, the 10^?9 M concentration of melatonin and the in vitro production phase in which it is used directly affected embryonic development and quality.     

Lactation feed disappearance and weaning to estrus interval for sows fed spray-dried plasma

Four experiments involving 265, 410, 894, and 554 sows (Exp. 1 to 4, respectively) were conducted to determine the effect of spray-dried plasma (SDP) at 0 or 0.25% (Exp. 1 and 2) and 0 or 0.50% (Exp. 3 and 4) in lactation diets on average daily feed disappearance (FD), sum of sow BW, fetal and placental loss from d 110 gestation to weaning (SWL), litter size at weaning, litter weight at weaning, and average days from weaning to first estrus (WEI). Experiments 1, 3, and 4 were conducted during summer months, and Exp. 2 was conducted during fall to winter months. Experiment 1 used only parity 1 and parity 2 sows and Exp. 4 used only mature (>2 parities) sows, whereas Exp. 2 and 3 used all parity groups. Sows fed SDP in Exp. 1 had increased (P < 0.01) FD and a tendency for reduced (P = 0.06) SWL and WEI (P = 0.06). Sows fed SDP in Exp. 2 had a tendency for increased (P = 0.09) sow BW at weaning and reduced (P = 0.09) SWL, whereas other variables were not different between diets. Parity 1 and 2 sows fed SDP in Exp. 3 had increased (P < 0.01) FD, but mature sows fed SDP had reduced (P = 0.02) FD. Pig survival and litter size at weaning for all parity groups was not different between diets. The WEI for parity 1 sows fed SDP was reduced (P = 0.02) and tended to be reduced (P = 0.10) for mature sows fed SDP, but was not different between diets for parity 2 sows. More parity 1 sows fed SDP were detected (P = 0.01) in estrus 4 to 6 d after weaning, and fewer were detected (P < 0.01) in estrus 6 d after weaning compared with control parity 1 sows. In Exp. 4, FD was reduced (P < 0.01) for mature sows fed SDP; however, litter weight and average pig BW at weaning was increased (P < 0.01) with more (P < 0.01) marketable pigs (pig BW > 3.6 kg) weaned per litter. Relatively low dietary levels of SDP (0.25 to 0.50%) fed to parity 1 sows farrowed during summer months increased lactation FD and reduced WEI. Mature sows fed SDP during summer months consumed less lactation feed without compromising WEI, but had an increased litter weight, average pig BW, and number of marketable pigs at weaning.     

Chronic metabolic acid load induced by changes in dietary electrolyte balance increased chloride retention but did not compromise bone in growing swine

The effects of chronic dietary acid loads on shifts in bone mineral reserves and physiological concentrations of cations and anions in extracellular fluids were assessed in growing swine. Four trials were conducted with a total of 38 (8.16 +/- 0.30 kg, mean +/- SEM) Large White x Landrace x Duroc pigs randomly assigned to one of three dietary treatments. Semipurified diets, fed for 13 to 17 d, provided an analyzed dietary electrolyte balance (dEB, meq/kg diet = Na+ + K+ - Cl-) of -35, 112, and 212 for the acidogenic, control, and alkalinogenic diets, respectively. Growth performance, arterial blood gas, serum chemistry, urine pH, mineral balance, bone mineral content gain, bone-breaking strength, bone ash, and percentage of bone ash were determined. Dietary treatments created a range of metabolic acid loads without affecting (P > 0.10) growth or feed intake. Urine pH was 5.71, 6.02, and 7.65 +/- 0.48 (mean +/- SEM) and arterial blood pH was 7.478, 7.485, and 7.526 +/- 0.006 for pigs fed acidogenic, control, and alkalinogenic treatments, respectively. A lower dEB resulted in an increased (P < 0.001) apparent Cl- retention (106.6, 55.4, and 41.2 +/- 6.3 meq/d), of which only 1.6% was accounted for by expansion of the extracellular fluid Cl- pool as calculated from serum Cl- (105.5, 103.4, 101.6 +/- 0.94 meq/L (mean +/- SEM) for pigs fed acidogenic, control, and alkalinogenic treatments, respectively. A lower dEB did not decrease (P > 0.10) bone mineral content gain, bone-breaking strength, bone ash, percentage of bone ash, or calcium and phosphate balance. In conclusion, bone mineral (phosphate) was not depleted to buffer the dietary acid load in growing pigs over a 3-wk period.     

Further assessment of the dietary lysine requirement of finishing gilts

A cooperative research study involving 635 gilts was conducted at eight research stations to further estimate the lysine requirement of finishing gilts. Dietary crude protein levels of the five dietary treatments ranged from 16.0 to 24.4% with calculated lysine levels of .80, .95, 1.10, 1.25, or 1.40%. Each station contributed a minimum of two replicate pens of pigs per treatment. Average initial and final weights were 53.6 and 116.4 kg, respectively. At the end of the experimental period, pigs were killed and hot carcass weight, 10th-rib fat depth, and longissimus muscle area were measured. Carcass fat-free lean percentage and fat-free lean gain were estimated from these data. Daily lysine intakes averaged 21.8, 25.9, 30.5, 34.3, and 37.8 g/d for the five treatment groups, respectively. Increasing the dietary lysine from .80 to .95% numerically increased weight gain and gain:feed, but these increases were not maintained at higher levels of dietary lysine. Overall, rate and efficiency of gain decreased (cubic, P < .01) with increasing dietary lysine. Carcasses were leaner at the two higher levels of dietary lysine as evidenced by reduced 10th rib backfat (linear, P < .01), increased longissimus area (quadratic, P < .04), and increased percentage of estimated fat-free lean (linear, P < .01). Carcass fat-free lean gain was not influenced by dietary lysine except for a small numerical improvement (P < .11) at the .95% level of dietary lysine that paralleled the improvement in body weight gain. The results indicate that the dietary lysine requirement of finishing gilts with a mean carcass fat-free lean growth rate of 306 g/d from 54 to 116 kg body weight is probably no higher than .80% of the diet to achieve maximum rate and efficiency of body weight gain and carcass lean growth rate. The results also indicate that higher dietary lysine levels may increase carcass leanness in finishing gilts, possibly due to reduced intake of NE. Whether this response is due to the effects of lysine alone, protein (i.e., other amino acids), or soybean meal is unknown.     

Variability among sources and laboratories in analyses of wheat middlings. NCR-42 Committee on Swine Nutrition

A cooperative research study was conducted by members of a regional committee (North Central Regional Committee on Swine Nutrition [NCR-42]) to assess the variability in nutrient composition (DM, CP, Ca, P, Se, NDF, and amino acids) of 14 sources of wheat middlings from 13 states (mostly in the Midwest). A second objective was to assess the analytical variability in nutrient assays among 20 laboratories (labs; 14 experiment station labs and six commercial labs). Wheat middlings were obtained from each participating station's feed mill. The bulk density of the middlings ranged from 289 to 365 g/L. The number of labs that analyzed samples were as follows: DM and CP, 20; Ca, 16; P, 15; Se, 7; NDF, 10; and amino acids, 9. Each lab used its own analytical procedures. The middlings averaged 89.6% DM, 16.2% CP, .12% Ca, .97% P, 36.9% NDF, .53 mg/kg Se, .66% lysine, .19% tryptophan, .54% threonine, .25% methionine, .34% cystine, .50% isoleucine, and .73% valine. As expected, there was considerable variation in nutrient composition among the 14 sources (P < .01), especially for Ca (.08 to .30%) and Se (.05 to 1.07 mg/kg). "Heavy" middlings (high bulk density, >335 g/L), having a greater proportion of flour attached to the bran, were lower in CP, lysine, P, and NDF than "light" middlings (<310 g/L), having cleaner bran, resulting in negative correlations between bulk density and CP (r = -.61), lysine (r = -.59), P (r = -.54), and NDF (r = -.81). Each 1-percentage-point increase in CP in the wheat middlings was associated with .0235 (r2 = .61) and 2.1 (r2 = .39)-percentage-point increases in lysine and NDF, respectively. Lysine content was associated with NDF, CP, and bulk density of wheat middlings (r2 = .88). There was considerable variation among laboratories (P < .01) in analysis of all nutrients. The CV among sources (100 x sigmaS/mean) was greater than among labs (100 x sigmaL/mean) for CP, Ca, P, Se, and NDF, but the CV among labs was greater than that among sources for DM and all of the amino acids except lysine and phenylalanine.     

Effects of ethanol extraction and duration of heat treatment of soybean flakes on the utilization of soybean protein by growing rats and pigs

Three experiments were conducted to determine the effects of ethanol extraction and duration of heat treatment of soybean flakes on the utilization of soybean protein by growing rats and pigs. In the first experiment, the treatments were no extraction or extraction with a 55% ethanol-water mixture (v/v), and heat treatments of 0, 5, 10, 20 and 40 min in an autoclave. Ethanol extraction improved rate (P less than .002) and efficiency of gain (P less than .001) of rats. As heat treatment was increased from 0 to 20 min, rate of gain increased, but it decreased again as heating time was increased from 20 to 40 min (P less than .03). In Exp. 2 and 3, 45 pigs were used in a growth assay and 54 were used in a N balance experiment to determine the effects of ethanol extraction on under-, intermediate- and over-processed soybean flakes (i.e., 5, 20 and 60 min of autoclaving). The heat treatments were applied either without, before or after extraction with ethanol. Responses in rate and efficiency of gain to ethanol extraction were greater for soybean flakes heated for either 5 or 60 min than for the soybean flakes heated for 20 min. When pooled across heat treatment, pigs fed the soybean flakes heated before or after extraction with ethanol gained faster (P less than .001), had greater gain:feed (P less than .001) and lower plasma urea concentrations (P less than .002) than pigs fed soybean flakes heated without extraction. Feeding soybean flakes heated and extracted with ethanol also resulted in greater apparent N retention (P less than .003), apparent N digestibility (P less than .001) and apparent biological value (P less than .03) than soybean flakes that were heated without extraction. Ethanol extraction improved the protein quality of soybean flakes, especially when the flakes were under- or overprocessed with heat.     

Hyoscine‐N‐butylbromide premedication on cardiovascular variables of horses sedated with medetomidine

ObjectiveTo evaluate the effects of intravenous (IV) or intramuscular (IM) hyoscine premedication on physiologic variables following IV administration of medetomidine in horses.Study designRandomized, crossover experimental study.AnimalsEight healthy crossbred horses weighing 330 ± 39 kg and aged 7 ± 4 years.MethodsBaseline measurements of heart rate (HR), cardiac index (CI), respiratory rate, systemic vascular resistance (SVR), percentage of patients with second degree atrioventricular (2^oAV) block, mean arterial pressure (MAP), pH, and arterial partial pressures of carbon dioxide (PaCO₂) and oxygen (PaO₂) were obtained 5 minutes before administration of IV hyoscine (0.14 mg kg^?1; group HIV), IM hyoscine (0.3 mg kg^?1; group HIM), or an equal volume of physiologic saline IV (group C). Five minutes later, medetomidine (7.5 μg kg^?1) was administered IV and measurements were recorded at various time points for 130 minutes.ResultsMedetomidine induced bradycardia, 2^oAV blocks and increased SVR immediately after administration, without significant changes in CI or MAP in C. Hyoscine administration induced tachycardia and hypertension, and decreased the percentage of 2^oAV blocks induced by medetomidine. Peak HR and MAP were higher in HIV than HIM at 88 ± 18 beats minute^?1 and 241 ± 37 mmHg versus 65 ± 16 beats minute^?1 and 192 ± 38 mmHg, respectively. CI was increased significantly in HIV (p ≤ 0.05). Respiratory rate decreased significantly in all groups during the recording period. pH, PaCO₂ and PaO₂ were not significantly changed by administration of medetomidine with or without hyoscine.Conclusion and clinical relevanceHyoscine administered IV or IM before medetomidine in horses resulted in tachycardia and hypertension under the conditions of this study. The significance of these changes, and responses to other dose rates, requires further investigation.